Company intelligence / Profile preview

Bene Meat Technologies

Prague, Prague, Czech Republicbenemeat.com ↗

Ownership: Private
Employees: ~80
Development stage: Commercial

Overview

Successfully registered cultivated meat as a feed ingredient for pet food in the European Union. First company in the world licensed to produce and sell cultured meat for dog and cat food as of November 7, 2023.

Therapeutic areas: Other
Modalities: Cultivated meat
Industry: Non-Drug Biotech

Drug pipeline

1 asset

Cultivated cells of mammalian origin

Commercial

Indications: Pet food

Partnerships

Collaborating with leading pet food manufacturers

Beyond the preview

Go deeper on Bene Meat Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bene Meat Technologies.

Explore the full profile